Lactate dehydrogenase in sickle cell disease

Clinica Chimica Acta

Volumn 458, Issue , 2016, Pages 99-102

  Stankovic Stojanovic, Katia ^a   Lionnet, François ^a  

^a HÔPITAL TENON   (France)

Author keywords

Hemolysis; Lactate dehydrogenase; Prognosis; Sickle cell disease

Indexed keywords

LACTATE DEHYDROGENASE;

DISEASE COURSE; ENDOTHELIUM INJURY; ENZYME ACTIVITY; HUMAN; INTRAVASCULAR HEMOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REPERFUSION INJURY; REVIEW; SICKLE CELL ANEMIA; THROMBOCYTE ACTIVATION; TISSUE NECROSIS; VASCULAR DISEASE; VASOCONSTRICTION; ANEMIA, SICKLE CELL; ENZYMOLOGY; HEMOLYSIS; METABOLISM;

ANEMIA, SICKLE CELL; HEMOLYSIS; HUMANS; L-LACTATE DEHYDROGENASE;

EID: 84966341174     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2016.04.035     Document Type: Review

References (49)

1. Vanderlinde R.E. Measurement of total lactate dehydrogenase activity. Ann. Clin. Lab. Sci. 1985, 15:13-31.
2. Neely C.L., Wajima T., Kraus A.P., Diggs L.W., Barreras L. Lactic acid dehydrogenase activity and plasma hemoglobin elevations in sickle cell disease. Am. J. Clin. Pathol. 1969, 52:167-169.
3. Stein I.D. Serum lactate dehydrogenase isoenzymes: stability, clearance, and diagnostic application in hemolytic anemia. J. Lab. Clin. Med. 1970, 76:76-84.
4. Huijgen H.J., Sanders G.T., Koster R.W., Vreeken J., Bossuyt P.M. The clinical value of lactate dehydrogenase in serum: a quantitative review. Eur. J. Clin. Chem. Clin. Biochem. 1997, 35:569-579.
5. Kato G.J., Gladwin M.T. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA 2008, 300:2638-2646.
6. Dutra F.F., Alves L.S., Rodrigues D., Fernandez P.L., de Oliveira R.B., Golenbock D.T., et al. Hemolysis-induced lethality involves inflammasome activation by heme. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E4110-E4118.
7. Kato G.J., McGowan V., Machado R.F., Little J.A., Taylor J.6th, CR Morris, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood 2006, 107:2279-2285.
8. Mecabo G., Yamamoto M., Biassi T.P., Figueiredo M.S. Lactate dehydrogenase isoenzyme 3 and hemolysis in sickle cell anemia: a possible correlation?. Blood 2015, 125:3821-3822.
9. Lionnet F., Hammoudi N., Stojanovic K.S., Avellino V., Grateau G., Girot R., et al. Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica 2012, 97:1136-1141.
10. Liem R.I., Young L.T., Thompson A.A. Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension. Haematologica 2007, 92:1549-1552.
11. Aliyu Z.Y., Gordeuk V., Sachdev V., Babadoko A., Mamman A.I., Akpanpe P., et al. Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. Am. J. Hematol. 2008, 83:485-490.
12. Machado R.F., Hildesheim M., Mendelsohn L., Remaley A.T., Kato G.J., Gladwin M.T. NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease. Br. J. Haematol. 2011, 154:512-520.
13. Novelli E.M., Hildesheim M., Rosano C., Vanderpool R., Simon M., Kato G.J., et al. Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease. PLoS One 2014, 9.
14. Nolan V.G., Adewoye A., Baldwin C., Wang L., Ma Q., Wyszynski D.F., et al. Sickle cell leg ulcers: associations with haemolysis and SNPs in Klotho, TEK and genes of the TGF-beta/BMP pathway. Br. J. Haematol. 2006, 133:570-578.
15. Cumming V., King L., Fraser R., Serjeant G., Reid M. Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia. Br. J. Haematol. 2008, 142:119-125.
16. Connes P., Lamarre Y., Hardy-Dessources M.D., Lemonne N., Waltz X., Mougenel D., et al. Decreased hematocrit-to-viscosity ratio and increased lactate dehydrogenase level in patients with sickle cell anemia and recurrent leg ulcers. PLoS One 2013, 8.
17. Nolan V.G., Wyszynski D.F., Farrer L.A., Steinberg M.H. Hemolysis-associated priapism in sickle cell disease. Blood 2005, 106:3264-3267.
18. Taylor J.G.6th, Nolan V.G., Mendelsohn L., Kato G.J., Gladwin M.T., Steinberg M.H. Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain. PLoS One 2008, 3.
19. Darbari D.S., Onyekwere O., Nouraie M., Minniti C.P., Luchtman-Jones L., Rana S., Sable C., Ensing G., Dham N., Campbell A., Arteta M., Gladwin M.T., Castro O., Taylor J.G.6th, Kato G.J., Gordeuk V. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J. Pediatr. 2012, 160:286-290.
20. Nouraie M., Lee J.S., Zhang Y., Kanias T., Zhao X., Xiong Z., et al. Walk-PHASST Investigators and Patients. The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe. Haematologica 2013, 98:464-472.
21. Milton J.N., Rooks H., Drasar E., McCabe E.L., Baldwin C.T., Melista E., Investigators Walk-PHAAST, Steinberg M.H., et al. Genetic determinants of haemolysis in sickle cell anaemia. Br. J. Haematol. 2013, 161:270-278.
22. Bernaudin F., Verlhac S., Arnaud C., Kamdem A., Vasile M., Kasbi F., Hau I., Madhi F., Fourmaux C., Biscardi S., Epaud R., Pondarré C. Chronic and acute anemia and extracranial internal carotid stenosis are risk factors for silent cerebral infarcts insickle cell anemia. Blood 2015 Mar 5, 125(10):1653-1661.
23. Bernaudin F., Verlhac S., Chevret S., Torres M., Coic L., Arnaud C., et al. G6PD deficiency, absence of alpha-thalassemia, and hemolytic rate at baseline are significant independent risk factors for abnormally high cerebral velocities in patients with sickle cell anemia. Blood 2008, 112:4314-4317.
24. O'Driscoll S., Height S.E., Dick M.C., Rees D.C. Serum lactate dehydrogenase activity as a biomarker in children with sickle cell disease. Br. J. Haematol. 2008, 140:206-209.
25. Domingos I.F., Falcão D.A., Hatzlhofer B.L., Cunha A.F., Santos M.N., Albuquerque D.M., et al. Influence of the βs haplotype and α-thalassemia on stroke development in a Brazilian population with sickle cellanaemia. Ann. Hematol. 2014, 93:1123-1129.
26. Onyekwere O.C., Campbell A., Teshome M., Onyeagoro S., Sylvan C., Akintilo A., et al. Pulmonary hypertension in children and adolescents with sickle cell disease. Pediatr. Cardiol. 2008, 29:309-312.
27. Guasch A., Navarrete J., Nass K., Zayas C.F. Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure. J. Am. Soc. Nephrol. 2006, 17:2228-2235.
28. Haymann J.P., Stankovic K., Levy P., Avellino V., Tharaux P.L., Letavernier E., et al. Glomerular hyperfiltration in adult sickle cell anemia: a frequent hemolysis associated feature. Clin. J. Am. Soc. Nephrol. 2010, 5:756-761.
29. Gurkan S., Scarponi K.J., Hotchkiss H., Savage B., Drachtman R. Lactate dehydrogenase as a predictor of kidney involvement in patients with sickle cell anemia. Pediatr. Nephrol. 2010, 25:2123-2127.
30. Hamideh D., Raj V., Harrington T., Li H., Margolles E., Amole F., et al. Albuminuria correlates with hemolysis and NAG and KIM-1 in patients with sickle cell anemia. Pediatr. Nephrol. 2014, 29:1997-2003.
31. Maier-Redelsperger M., Lévy P., Lionnet F., Stankovic K., Haymann J.P., Lefèvre G., et al. Strong association between a new marker of hemolysis and glomerulopathy in sickle cell anemia. Blood Cells Mol. Dis. 2010, 45:289-292.
32. Asnani M.R., Fraser R.A., Reid M.E. Higher rates of hemolysis are not associated with albuminuria in Jamaicans with sickle cell disease. PLoS One 2011, 6.
33. Raj V.M., Freundlich M., Hamideh D., Alvarez O., Seeherunvong W., Abitbol C., et al. Abnormalities in renal tubular phosphate handling in children with sickle cell disease. Pediatr. Blood Cancer 2014, 61:2267-2270.
34. Maurel S., Stankovic Stojanovic K., Avellino V., Girshovich A., Letavernier E., Grateau G., et al. Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease. Clin. J. Am. Soc. Nephrol. 2014, 9:648-653.
35. Arteta M., Campbell A., Nouraie M., Rana S., Onyekwere O.C., Ensing G., et al. Abnormal pulmonary function and associated risk factors in children and adolescents with sickle cell anemia. J. Pediatr. Hematol. Oncol. 2014, 36:185-189.
36. Baldanzi G., Traina F., Marques Neto J.F., Santos A.O., Ramos C.D., Saad S.T. Low bone mass density is associated with hemolysis in Brazilian patients with sickle cell disease. Clinics (Sao Paulo) 2011, 66:801-805.
37. Bolarin D.M. Bone-specific alkaline phosphatase protein, total alkaline phosphatase activity and lactate dehydrogenase in sera of patients with sickle cell disease. Haematologia (Budap) 2001, 31:51-56.
38. Abhishek K., Sohail M., Kumar R., Patra P.K., Choudhary S.B. Mutation -538 T/C in bone morphogenetic protein 4 do not increase the risk in sickle-cell disease with orthopedic complications but strongly associated with increased LDH and uric acid level in Indian patients from Chhattisgarh and Jharkhand states. Clin. Chim. Acta 2010, 411:664-670.
39. Chen J., Hobbs W.E., Le J., Lenting P.J., de Groot P.G., López J.A. The rate of hemolysis in sickle cell disease correlates with the quantity of active von Willebrand factor in the plasma. Blood 2011, 117:3680-3683.
40. Charache S., Terrin M.L., Moore R.D., Dover G.J., Barton F.B., Eckert S.V., et al. Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the multicenter study of hydroxyurea in sickle cell anemia. N. Engl. J. Med. 1995, 332:1317-1322.
41. Voskaridou E., Christoulas D., Bilalis A., Plata E., Varvagiannis K., Stamatopoulos G., et al. The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). Blood 2010, 115:2354-2363.
42. Ballas S.K., Marcolina M.J. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006, 46:105-110.
43. Najim O.A., Hassan M.K. Lactate dehydrogenase and severity of pain in children with sickle cell disease. Acta Haematol. 2011, 126:157-162.
44. Stankovic Stojanovic K., Steichen O., Lefevre G., Bachmeyer C., Avellino V., Grateau G., et al. High lactate dehydrogenase levels at admission for painful vaso-occlusive crisis is associated with severe outcome in adult SCD patients. Clin. Biochem. 2012, 45:1578-1582.
45. Mekontso Dessap A., Deux J.F., Abidi N., Lavenu-Bombled C., Melica G., Renaud B., et al. Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am. J. Respir. Crit. Care Med. 2011, 184:1022-1029.
46. Vidler J.B., Gardner K., Amenyah K., Mijovic A., Thein S.L. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience. Br. J. Haematol. 2015, 169:746-753.
47. Ataga K.I., Orringer E.P. Bone marrow necrosis in sickle cell disease: a description of three cases and a review of the literature. Am J Med Sci 2000, 320:342-347.
48. Neuman G., Boodhan S., Wurman I., Koren G., Bitnun A., Kirby-Allen M., et al. Ceftriaxone-induced immune hemolytic anemia. Ann. Pharmacother. 2014, 48:1594-1604.
49. Kato G.J., Nouraie S.M., Gladwin M.T. Lactate dehydrogenase and hemolysis in sickle cell disease. Blood 2013, 122:1091-1092.